TELA Bio Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
TELA Bio, Inc. (TELA) Misses Q2 EPS by 28c
August 10, 2022 4:28 PM EDTTELA Bio, Inc. (NASDAQ: TELA) reported Q2 EPS of ($0.88), $0.28 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $10.12 million.
GUIDANCE:
TELA Bio, Inc. sees FY2022 revenue of $42-45 million, versus the... More
